Spots Global Cancer Trial Database for locally advanced gastric carcinoma
Every month we try and update this database with for locally advanced gastric carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1 | NCT05593458 | Locally Advance... | Oxaliplatin by ... SOX neoadjuvant Sintilimab neoa... gastrectomy plu... SOX adjuvant, S... Sintilimab adju... | 18 Years - 75 Years | Zhejiang University | |
| Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration | NCT06396143 | Locally Advance... | 18 Years - 75 Years | Zhejiang University | ||
| Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy | NCT03223740 | Locally Advance... | Arm 1 pre-opera... Arm 2 post oper... | 18 Years - 75 Years | Sichuan Provincial People's Hospital | |
| Toripalimab Plus FLOT in Locally Advanced Gastric Cancer | NCT04891016 | Chemotherapy Immune Checkpoi... Locally Advance... | delayed toripal... control | 18 Years - 70 Years | Henan Cancer Hospital | |
| Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1 | NCT05593458 | Locally Advance... | Oxaliplatin by ... SOX neoadjuvant Sintilimab neoa... gastrectomy plu... SOX adjuvant, S... Sintilimab adju... | 18 Years - 75 Years | Zhejiang University | |
| Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration | NCT06396143 | Locally Advance... | 18 Years - 75 Years | Zhejiang University | ||
| Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | NCT02048540 | Locally Advance... | Bevacizumab docetaxel oxali... Gastrectomy | 18 Years - 70 Years | Chinese PLA General Hospital | |
| Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | NCT02048540 | Locally Advance... | Bevacizumab docetaxel oxali... Gastrectomy | 18 Years - 70 Years | Chinese PLA General Hospital | |
| Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy | NCT03223740 | Locally Advance... | Arm 1 pre-opera... Arm 2 post oper... | 18 Years - 75 Years | Sichuan Provincial People's Hospital | |
| Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations | NCT04550494 | Advanced Pancre... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HER2-Positive B... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Brea... Metastatic Gast... Metastatic Mali... Metastatic Ovar... Metastatic Panc... Metastatic Pros... Platinum-Sensit... Stage II Pancre... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Talazoparib | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors | NCT06364410 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Locally Advance... Locally Advance... Locally Advance... Metastatic Gast... Metastatic Gast... Metastatic Mali... Unresectable Ga... Unresectable Ga... Unresectable Ma... | Azenosertib Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Magnetic Resona... Multigated Acqu... Trastuzumab Der... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors | NCT06364410 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Locally Advance... Locally Advance... Locally Advance... Metastatic Gast... Metastatic Gast... Metastatic Mali... Unresectable Ga... Unresectable Ga... Unresectable Ma... | Azenosertib Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Magnetic Resona... Multigated Acqu... Trastuzumab Der... | 18 Years - | National Cancer Institute (NCI) | |
| Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration | NCT06396143 | Locally Advance... | 18 Years - 75 Years | Zhejiang University | ||
| Toripalimab Plus FLOT in Locally Advanced Gastric Cancer | NCT04891016 | Chemotherapy Immune Checkpoi... Locally Advance... | delayed toripal... control | 18 Years - 70 Years | Henan Cancer Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
